Related references
Note: Only part of the references are listed.Programmed cell death-ligand 1 (PD-L1) expression and fibroblast growth factor receptor 1 (FGFR1) amplification in stage III/IV lung squamous cell carcinoma (SQC)
Qinxiang Guo et al.
THORACIC CANCER (2017)
The expression of PD-Ll protein as a prognostic factor in lung squamous cell carcinoma
Kazuki Takada et al.
LUNG CANCER (2017)
Lung cancer in patients with idiopathic pulmonary fibrosis
Theodoros Karampitsakos et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2017)
Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment
Genichiro Ishii et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
PD-L1 expression in human cancers and its association with clinical outcomes
Xin Wang et al.
ONCOTARGETS AND THERAPY (2016)
The Impact of Lung Cancer on Survival of Idiopathic Pulmonary Fibrosis
Sara Tomassetti et al.
CHEST (2015)
The prognostic value of PD-L1 expression for non-small cell lung cancer patients: A meta-analysis
A. Wang et al.
EJSO (2015)
Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases
Toshihiko Sato et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2015)
Combination cancer immunotherapy and new immunomodulatory targets
Kathleen M. Mahoney et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
Bin Shang et al.
SCIENTIFIC REPORTS (2015)
Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall- cell lung cancer
K. Azuma et al.
ANNALS OF ONCOLOGY (2014)
Level of circulating PD-L1 expression in patients with advanced gastric cancer and its clinical implications
Zhixue Zheng et al.
CHINESE JOURNAL OF CANCER RESEARCH (2014)
Podoplanin-Positive Cancer-Associated Fibroblasts Could Have Prognostic Value Independent of Cancer Cell Phenotype in Stage I Lung Squamous Cell Carcinoma Usefulness of Combining Analysis of Both Cancer Cell Phenotype and Cancer-Associated Fibroblast Phenotype
Shotaro Ono et al.
CHEST (2013)
PD-L1 Expression by Neurons Nearby Tumors Indicates Better Prognosis in Glioblastoma Patients
Yawei Liu et al.
JOURNAL OF NEUROSCIENCE (2013)
Lung Cancer and Interstitial Lung Diseases: A Systematic Review
Kostas Archontogeorgis et al.
PULMONARY MEDICINE (2012)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation
Chuan-Yong Mu et al.
MEDICAL ONCOLOGY (2011)
Cumulative incidence of and predictive factors for lung cancer in IPF
Yuichi Ozawa et al.
RESPIROLOGY (2009)
Expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells:: Applicability to tumor-infiltrating T regulatory cells
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK
Ivan Le Jeune et al.
RESPIRATORY MEDICINE (2007)
The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Tumor infiltrating FOXP3+ regulatory T-cells are associated with recurrence in pathologic stage INSCLC patients
Rebecca P. Petersen et al.
CANCER (2006)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis
A Pardo et al.
PLOS MEDICINE (2005)
Epithelial-stromal interactions in the mouse and human mammary gland in vivo
H Parmar et al.
ENDOCRINE-RELATED CANCER (2004)